Video Experimental Relacionado

Updated: May 7, 2026

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Informe de caso: Crioanalgesia para el dolor torácico intratable debido al tumor de la pared torácica

Thays Sellan Paim¹, Myrna Guernelli¹, Rafael Soares Simoneti¹

¹Department of Thoracic Surgery, Universidade Federal de São Paulo, São Paulo, Brazil.

Frontiers in oncology

|August 22, 2025

Resumen

Cryoanalgesia ofrece alivio del dolor a largo plazo para el dolor de cirugía torácica severa. Esta técnica de crianalgesia proporciona un control efectivo del dolor con efectos secundarios mínimos, mejorando la recuperación del paciente.

Área de la Ciencia:

Cirugía torácica
Tratamiento del dolor
En el campo de la oncología

Sus antecedentes:

El dolor postoperatorio en la cirugía torácica afecta significativamente la recuperación del paciente.
El dolor torácico severo puede ser refractario a la analgesia opiácea convencional.
Cryoanalgesia presenta una opción no farmacológica para el alivio del dolor sostenido.

Objetivo del estudio:

Evaluar la eficacia de la crioanalgesia para el tratamiento del dolor postoperatorio severo en la cirugía torácica.
Presentar un estudio de caso de un paciente con dolor torácico refractario debido a tumores carcinoides tratados con crioanalgesia.

Principales métodos:

Crioanalgesia que utiliza el óxido nitroso presurizado para inducir un bloqueo nervioso periférico temporal.
Bloqueo del nervio intercostal para el tratamiento inmediato del dolor.
La resección quirúrgica de lesiones torácicas y suprarrenales.

Principales resultados:

La crioanalgesia proporcionó un alivio efectivo y a largo plazo del dolor en un paciente con dolor torácico severo que no respondió a los opioides.
El paciente experimentó una excelente recuperación y permaneció sin dolor un año después del tratamiento.
Se observaron efectos secundarios mínimos y no se observaron interacciones farmacológicas con la crioanalgesia.

Conclusiones:

La crioanalgesia es un tratamiento eficaz para el dolor torácico severo asociado con tumores torácicos.
Ofrece una opción valiosa y mínimamente invasiva para el manejo del dolor en la cirugía torácica.
La mejora de la recuperación y el control del dolor a largo plazo hacen de la crianalgesia una consideración clave en las estrategias de dolor multimodal.

Palabras clave:

Tumor carcinoide Informe de caso dolor en el pecho Crioanalgesia cirugía torácica pared torácica

Más Videos Relacionados

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

Videos de Conceptos Relacionados

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Pericarditis IV: Nursing Management

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.

Peripheral Artery Disease V: Postoperative Nursing Management

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...